🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome

RecruitingNAAges 18 Years - 89 YearsAllMalcom Randall VA Medical Center
NCT06983496 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary Exclusion Criteria: * Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility * Unable to participate in telehealth
💊

What it tests

  • Post-ICU Telehealth Follow-up
📍

Where

1 site
Malcom Randall Veterans Affairs Medical Center
Gainesville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy